Knowledge translation initiative to support the implementation of CHAP across Canada*
Dr. Janusz Kaczorowski, Université de Montréal
Lisa Dolovich, University of Toronto
Tamara Daly, York University
Marie-Thérèse Lussier, Université de Montréal
Gina Agarwal , McMaster University
Maria Chiu, University of Toronto
The proposed knowledge translation strategy applies more than 15 years of research conducted as part of the Cardiovascular Health Awareness Program (CHAP) to reduce the impact of vascular disease (CVD) on the health of Canadians. The main objective is to move knowledge into action by addressing three key stages of the knowledge-to-action cycle: 1) adapt CHAP knowledge to the local context, 2) assess barriers to CHAP knowledge use, and 3) select, tailor and implement CHAP interventions. An effective knowledge translation strategy that takes into account the decentralised nature of the Canadian system, will increase awareness and facilitate wide scale implementation and sustainability of the program, and thus improve the prevention and management of cardiovascular disease of adults in Canada.
IMPRESS Canada: Improving Preclinical Reporting and Experimental Study deSign of Canadian cardiovascular researchers**
Dr. Manoj Lalu, Ottawa Hospital Research Institute
Dean Fergusson, Ottawa Hospital Research Institute
Justin Presseau, Ottawa Hospital Research Institute
Kelly Cobey, Ottawa Hospital Research Institute
Jamie Brehaut, Ottawa Hospital Research Institute
Our team is studying the barriers and facilitators to improving methodological rigour at the bench (e.g. implementing randomization and blinding). We have operationalized the NIH’s Principles and Guidelines for Reporting Preclinical Research into a reporting assessment checklist. Based on this checklist we have initiated an assessment of reporting practices of CVN basic science/preclinical researchers. At this time we are hiring a Research Assistant to help lead upcoming interviews of CVN researchers and senior trainees. We hope to engage the CVN community and bring increased rigour to preclinical work conducted by our researchers.